WO2002032930A3 - Haplotypes du gene scya21 - Google Patents

Haplotypes du gene scya21 Download PDF

Info

Publication number
WO2002032930A3
WO2002032930A3 PCT/US2001/046141 US0146141W WO0232930A3 WO 2002032930 A3 WO2002032930 A3 WO 2002032930A3 US 0146141 W US0146141 W US 0146141W WO 0232930 A3 WO0232930 A3 WO 0232930A3
Authority
WO
WIPO (PCT)
Prior art keywords
scya21
gene
haplotypes
disclosed
cys
Prior art date
Application number
PCT/US2001/046141
Other languages
English (en)
Other versions
WO2002032930A2 (fr
Inventor
Steven C Bentivegna
David P Russo
Original Assignee
Genaissance Pharmaceuticals
Steven C Bentivegna
David P Russo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genaissance Pharmaceuticals, Steven C Bentivegna, David P Russo filed Critical Genaissance Pharmaceuticals
Priority to AU2002227177A priority Critical patent/AU2002227177A1/en
Publication of WO2002032930A2 publication Critical patent/WO2002032930A2/fr
Publication of WO2002032930A3 publication Critical patent/WO2002032930A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne de nouveaux variants génétiques du gène 21 (SCYA21) membre de la sous-famille A des petites cytokines inductibles (Cys-Cys) ainsi que divers génotypes, haplotypes et paires d'haplotypes, existant au sein de la population générale des Etats-Unis, pour le gène SCYA21. Cette invention concerne également des compositions et des méthodes d'haplotypage et/ou de génotypage du gène SCYA21 chez un individu ainsi que des polynucléotides définis par les haplotypes décrits.
PCT/US2001/046141 2000-10-19 2001-10-09 Haplotypes du gene scya21 WO2002032930A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002227177A AU2002227177A1 (en) 2000-10-19 2001-10-09 Haplotypes of the scya21 gene

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24162200P 2000-10-19 2000-10-19
US60/241,622 2000-10-19

Publications (2)

Publication Number Publication Date
WO2002032930A2 WO2002032930A2 (fr) 2002-04-25
WO2002032930A3 true WO2002032930A3 (fr) 2002-10-10

Family

ID=22911470

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/046141 WO2002032930A2 (fr) 2000-10-19 2001-10-09 Haplotypes du gene scya21

Country Status (2)

Country Link
AU (1) AU2002227177A1 (fr)
WO (1) WO2002032930A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2459582B1 (fr) 2009-07-30 2015-05-27 Merck Sharp & Dohme Corp. Inhibiteurs de protéase ns3 du virus de l'hépatite c

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE GENBANK [online] 1 February 2000 (2000-02-01), NAGIRA ET AL.: "Homo sapiens mRNA for SLC, complete cds", XP002951625, accession no. NCBI Database accession no. (AB002409.1) *
DATABASE GENBANK [online] 7 January 1999 (1999-01-07), REITERER: "Homo sapiens slc gene, exons 1 to 4", XP002951626, accession no. NCBI Database accession no. (AJ005654.1) *
NAGIRA ET AL.: "Molecular cloning of a novel human CC chemokine secondary lymphoid-tissue chemokine that is a potent chemoattractant for lymphocytes and mapped to chromosome 9p13", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 272, no. 31, August 1997 (1997-08-01), pages 19518 - 19524, XP002937425 *

Also Published As

Publication number Publication date
WO2002032930A2 (fr) 2002-04-25
AU2002227177A1 (en) 2002-04-29

Similar Documents

Publication Publication Date Title
WO2002038589A3 (fr) Haplotypes du gene cyp2d6
WO2002032930A3 (fr) Haplotypes du gene scya21
WO2002016400A3 (fr) Haplotypes du gene scya26
WO2002026764A3 (fr) Haplotypes du gene ccr6
WO2002032927A3 (fr) Haplotypes du gene scya20
WO2002046209A3 (fr) Haplotypes du gene cyp3a5
WO2002010454A3 (fr) Haplotypes du gene alas2? ¿
WO2002016399A3 (fr) Haplotypes du gene tacr1
WO2002062820A3 (fr) Haplotypes du gene cyp27b1
WO2001090118A3 (fr) Haplotypes du gene edn2
WO2002040502A3 (fr) Haplotypes du gene de la lipase hormono-sensible
WO2002012561A3 (fr) Haplotypes du gene or1g1
WO2002090378A3 (fr) Haplotypes du gene de ces2
WO2002002580A3 (fr) Haplotypes du gene etfb
WO2002012499A3 (fr) Haplotypes du gene ntf3
WO2002020556A3 (fr) Haplotypes du gene gpr68
WO2002038586A3 (fr) Haplotypes du gene il6
WO2002010190A3 (fr) Haplotypes du gene il12b
WO2002022651A3 (fr) Haplotypes du gene ccr8
WO2001087908A3 (fr) Haplotypes du gene ccr3
WO2002094850A3 (fr) Haplotypes du gene gnrh2
WO2002038587A3 (fr) Haplotypes du gene grm8
WO2001090128A3 (fr) Haplotypes du gene gpr3
WO2001094362A3 (fr) Haplotypes du gene acp2
WO2001087907A3 (fr) Haplotypes du gene de l'osm

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WPC Withdrawal of priority claims after completion of the technical preparations for international publication

Ref country code: WO

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP